10,348 Shares in Waldencast plc (NASDAQ:WALD) Purchased by Marshall Wace LLP

Marshall Wace LLP bought a new position in Waldencast plc (NASDAQ:WALDFree Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 10,348 shares of the company’s stock, valued at approximately $37,000.

Several other large investors also recently modified their holdings of the business. Renaissance Technologies LLC purchased a new stake in Waldencast in the second quarter worth about $239,000. Bleakley Financial Group LLC purchased a new stake in Waldencast in the first quarter worth about $142,000. Norden Group LLC purchased a new stake in Waldencast in the first quarter worth about $92,000. Finally, Catalina Capital Group LLC purchased a new position in shares of Waldencast during the first quarter valued at approximately $73,000. 41.97% of the stock is owned by institutional investors.

Waldencast Price Performance

Shares of NASDAQ WALD opened at $3.32 on Monday. The firm’s 50-day moving average price is $3.40 and its 200-day moving average price is $4.11. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.78 and a current ratio of 1.47. Waldencast plc has a 12-month low of $2.40 and a 12-month high of $12.00.

Analyst Ratings Changes

WALD has been the subject of several analyst reports. DA Davidson raised their price target on shares of Waldencast from $6.50 to $7.25 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Telsey Advisory Group reaffirmed an “outperform” rating and issued a $6.00 target price on shares of Waldencast in a research report on Wednesday, October 9th.

Read Our Latest Stock Analysis on WALD

Waldencast Profile

(Free Report)

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.

Featured Articles

Institutional Ownership by Quarter for Waldencast (NASDAQ:WALD)

Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.